Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label
Go back to Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.06 -0.2 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.26 | 52 Week High | $63.73 | |||
| Open | $17.26 | 52 Week Low | $8.00 | |||
| Day High | $17.41 | P/E | N/A | |||
| Day Low | $16.94 | EPS | $-5.69 | |||
| Volume | 1,180,868 | |||||
